HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

523.445

+10.6722.08%

Number of Gainers:20

Number of Losers:8

Number of Flat:5

PE:- -

High:540.538

Open:513.718

Low:513.718

Close:512.773

Volume:144.53M

Turnover:5.04B

Market Cap:335.16B

Float Cap:297.75B

Loading ...

Boston Scientific Hit by Cyberattack, Shares Slide on Delivery Disruption

Unlocking Pipeline Value: Discovering A-Share Innovative Drug Investment Opportunities Through a DCF Lens

Microport Cardioflow Medtech Says Zhang Ruinian Has Resigned as CEO

MP CARDIOFLOW-B Announces New Leadership Appointments

MicroPort CardioFlow Delays Board Meeting on Interim Results Release

MicroPort CardioFlow Files Board and Committee Member List with Disclosure Roles

Microport Cardioflow Medtech - Zhang Ruinian Has Resigned as Chief Executive Officer, Appointed as President

THOMSON REUTERS

Microport Cardioflow Medtech - Brian Chang Has Been Appointed as Chairman

THOMSON REUTERS

MicroPort CardioFlow Names Chen Guoming CEO, Replacing Zhang Ruinian

BIOSTAR PHARM-B (02563) Reports Interim Results with Net Loss Narrowing 50.8% to RMB 26.596 Million

ACFTU Launches Second National Team Leader Competition With Ten Industry Tracks Including Rail, Power, Pharma, Machinery, Metallurgy, Building Materials, Defense Tech, ICT, Light Industry, and Textiles

China's Top Innovative Drugmaker Sees Profits Surge Sixfold, Market Cap Reaches 430 Billion Yuan

Lee's Pharmaceutical Flags Higher Interim Profit as Revenue and Margins Improve

CanSino Biologics, deepGeneAI Agree to Develop Personalized mRNA Cancer Vaccines

MT Newswires Live

Financial Heavyweights Drive Gains as Multiple Sectors Rally on Policy Support and Solid Earnings

RemeGen (SEHK:9995) Stock Profit Surge Meets Doubts Over Earnings Durability

Simply Wall St.

Jiangsu Unveils Plan to Encourage Inclusion of Innovative Drugs in Commercial Health Insurance and Mutual Aid Coverage

Citi Lifts REMEGEN Price Target to HK$127.7, Keeps Buy/High-Risk Call

CLSA Raises REMEGEN Price Target to HK$144.8, Reiterates Outperform Rating on Strong Q2 Beat

Delisting Doesn't Halt Claims! Investors in Poly Pharm (300630) File Another Court Case

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au.tigermarketb.com/stock/BK1574/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":523.44507,"timestamp":1787731681268,"preClose":512.7729,"halted":0,"volume":144532433,"delay":0,"changeRate":0.020813,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":10.67218,"latestTime":"08-26 16:00:00","open":513.7177,"high":540.53845,"low":513.7177,"amount":5035978891.5,"amplitude":0.052305,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787794200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787707800000,1787716800000],[1787720400000,1787731200000]],"pbRate":3.84011,"peRate":154.066227,"turnoverRate":0.005158,"increases":21,"decrements":10,"flats":2,"marketCap":335159009712,"floatMarketCap":297749782856},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":540.53845,"amplitude":0.052305,"preClose":512.7729,"low":513.7177,"pbRate":"3.84011","latestPrice":523.44507,"volume":144532433,"delay":0,"open":513.7177,"prevYearClose":556.26263,"prevWeekClose":506.075,"prevMonthClose":473.313,"prevQuarterClose":453.519,"fiveDayClose":492.831,"twentyDayClose":481.996,"sixtyDayClose":519.865,"secType":"PLATE","market":"HK","turnoverRate":0.005158,"peRate":154.066227,"marketCap":335159009712,"floatMarketCap":297749782856,"timestamp":1787731681268,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":20,"down":8,"flat":5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1163553180","title":"Boston Scientific Hit by Cyberattack, Shares Slide on Delivery Disruption","url":"https://stock-news.laohu8.com/highlight/detail?id=1163553180","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163553180?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:30","pubTimestamp":1787758250,"startTime":"0","endTime":"0","summary":"Boston Scientific disclosed in a Wednesday filing with the U.S. Securities and Exchange Commission (SEC) that it has been struck by a cyberattack, impacting its business operations. The incident is...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2244417387.USD","LU2112291526.USD","BK1574","BK4588","MEDX","LU0823416689.USD","LU1791710582.SGD","RSPH","HAKY","LU1718418525.SGD","IEIH","SG9999001176.USD","WCBR","IE00B2B36J28.USD","LU1989764664.SGD","LU2324357040.USD","SGXZ57979304.SGD","PTH","BK4581","LU0950375773.USD","LU2491050071.SGD","LU2362540622.SGD","BK1100","IE0002141913.USD","LU1804176565.USD","LU0345769631.USD","LU2357305700.SGD","LU0882574055.USD","LU0238689110.USD","LU1291159041.SGD","HART","LU1720051108.HKD","LU0011850046.USD","LU0267386448.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","BK4504","LU0353189763.USD","LU2491049909.HKD","LU0077335932.USD","LU0251132253.USD","LU0345769128.USD","LU0138981039.USD","LNGR","LU0187121727.USD","LU1989764748.USD","SG9999001176.SGD","LU0114720955.EUR","09996","LU0225283273.USD","LU1989772840.SGD","LU0528227936.USD","IE00BJT1NW94.SGD","LU1720051017.SGD","SPAM","LU1057294990.SGD","LU1791710400.SGD","BK4082","LU1061106388.HKD","GDOC","LU0353189680.USD","LU0823417653.USD","LU1548497426.USD","LU2506952170.USD","LU1983299246.USD","LU0823417737.USD","LGHT","BSX","LU0122379950.USD","LU2506952097.USD","UCYB","LU1153585028.USD","LU2265009873.SGD","LU2506951958.HKD","LU1989772923.USD","LU1989771016.USD","BK4585","LU2362541273.HKD","LU2362541513.USD","LU0432979614.USD","MDEV","LU2491050154.USD","LU0266013472.USD","SG9999013999.USD","IE0009355771.USD","LU0048584097.USD","LU2506951875.HKD","LU2087625088.SGD","AGNG","159883","IE00B4R5TH58.HKD","LU1023059063.AUD","BK1583","LU1366192091.USD","LU2242649171.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125221751","title":"Unlocking Pipeline Value: Discovering A-Share Innovative Drug Investment Opportunities Through a DCF Lens","url":"https://stock-news.laohu8.com/highlight/detail?id=1125221751","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125221751?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:20","pubTimestamp":1787757649,"startTime":"0","endTime":"0","summary":"The innovative drug industry is defined by its \"double ten\" characteristics—a research and development cycle of roughly a decade and an investment of about one billion US dollars per molecule. During...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1574","IBBQ","BK1161","MEDX","LNGR","06978","DCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662106748","title":"Microport Cardioflow Medtech Says Zhang Ruinian Has Resigned as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2662106748","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662106748?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:08","pubTimestamp":1787756895,"startTime":"0","endTime":"0","summary":"BRIEF-Microport Cardioflow Medtech Says Zhang Ruinian Has Resigned As CEOAug 26 -Microport Cardioflow Medtech Corp2160.HK:ZHANG RUINIAN HAS RESIGNED AS CHIEF EXECUTIVE OFFICER, APPOINTED AS PRESIDENTCHEN GUOMING RESIGNED AS CHAIRMAN, RE-DESIGNATED TO EXECUTIVE DIRECTOR, APPOINTED AS CEOBRIAN CHANG HAS BEEN APPOINTED AS CHAIRMANFurther company coverage:2160.HK","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N169:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","BK1100","02160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128341122","title":"MP CARDIOFLOW-B Announces New Leadership Appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=1128341122","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128341122?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:02","pubTimestamp":1787756533,"startTime":"0","endTime":"0","summary":"MP CARDIOFLOW-B (02160) has announced a series of executive changes effective August 26, 2026. Mr. Zhang Ruinian has stepped down from his role as Chief Executive Officer and has been appointed as...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1225","BK1100","BK1574","BK1583","02160","02918","BK1239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662573748","title":"MicroPort CardioFlow Delays Board Meeting on Interim Results Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2662573748","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662573748?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:58","pubTimestamp":1787756331,"startTime":"0","endTime":"0","summary":"MicroPort CardioFlow delays board meeting on interim results releaseMicroPort CardioFlow Medtech rescheduled its board meeting to Aug. 31, 2026, from Aug. 26, 2026.Session will review interim results ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL6mSG1y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1100","00853","02160","BK1589","BK1585","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662574857","title":"MicroPort CardioFlow Files Board and Committee Member List with Disclosure Roles","url":"https://stock-news.laohu8.com/highlight/detail?id=2662574857","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662574857?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:58","pubTimestamp":1787756324,"startTime":"0","endTime":"0","summary":"MicroPort CardioFlow files board and committee member list with disclosure rolesMicroPort CardioFlow Medtech (2160) updated its board and committee lineup in a filing dated Aug. 26, 2026.Brian Chang l","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL7XTd8n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1585","00853","BK1574","BK1583","BK1589","02160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662748578","title":"Microport Cardioflow Medtech - Zhang Ruinian Has Resigned as Chief Executive Officer, Appointed as President","url":"https://stock-news.laohu8.com/highlight/detail?id=2662748578","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662748578?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:58","pubTimestamp":1787756316,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N169:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1100","02160","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662485717","title":"Microport Cardioflow Medtech - Brian Chang Has Been Appointed as Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2662485717","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662485717?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:58","pubTimestamp":1787756316,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N169:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","02160","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662748576","title":"MicroPort CardioFlow Names Chen Guoming CEO, Replacing Zhang Ruinian","url":"https://stock-news.laohu8.com/highlight/detail?id=2662748576","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662748576?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:58","pubTimestamp":1787756289,"startTime":"0","endTime":"0","summary":"MicroPort CardioFlow names Chen Guoming CEO, replacing Zhang RuinianMicroPort CardioFlow Medtech named Guoming Chen chief executive, replacing Ruinian Zhang, effective Aug. 26, 2026.Chen stepped down ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDLb6bRcx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1100","BK1583","BK1589","BK1585","00853","02160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120341827","title":"BIOSTAR PHARM-B (02563) Reports Interim Results with Net Loss Narrowing 50.8% to RMB 26.596 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1120341827","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120341827?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:52","pubTimestamp":1787755941,"startTime":"0","endTime":"0","summary":"BIOSTAR PHARM-B (02563) has announced its interim results for 2026, recording revenue of RMB 36.635 million, a year-on-year increase of 147.8%. Gross profit reached RMB 34.08 million, up 147.9%...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1574","BK1161","09939","159938","02563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187289311","title":"ACFTU Launches Second National Team Leader Competition With Ten Industry Tracks Including Rail, Power, Pharma, Machinery, Metallurgy, Building Materials, Defense Tech, ICT, Light Industry, and Textiles","url":"https://stock-news.laohu8.com/highlight/detail?id=1187289311","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187289311?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:11","pubTimestamp":1787753476,"startTime":"0","endTime":"0","summary":"The All-China Federation of Trade Unions (ACFTU) General Office has issued a notice to fully launch the second National Team Leader Competition, aiming to strengthen enterprise team building, better...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","THMZ","PLTI","PLTW","JEDI","ROKT","LOUP","PLTZ","PTIR","CRTC","AMMO","BTHM","159938","DRNL","FITE","PLTA","159146","PLTU","PLOO","WAR","BK1161","PLTD","PLYY","PLTY","BK1574","BK1515","USMD","PLTL","XDEF","PLTG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142229559","title":"China's Top Innovative Drugmaker Sees Profits Surge Sixfold, Market Cap Reaches 430 Billion Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1142229559","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142229559?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:10","pubTimestamp":1787753427,"startTime":"0","endTime":"0","summary":"BeiGene Ltd (SH: 688235), trading at 279.00 yuan per share with a market capitalization of 430.298 billion yuan, released its semi-annual report for 2026 on August 26. The report reveals that the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","159992","IBBQ","MEDX","BK1574","BK1161","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184470015","title":"Lee's Pharmaceutical Flags Higher Interim Profit as Revenue and Margins Improve","url":"https://stock-news.laohu8.com/highlight/detail?id=1184470015","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184470015?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:28","pubTimestamp":1787750895,"startTime":"0","endTime":"0","summary":"Lee's Pharmaceutical Holdings Ltd (00950) has issued a positive profit alert, indicating that the group expects to report an audited net profit attributable to shareholders of between approximately...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1574","00950","BK1587","06622","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662160207","title":"CanSino Biologics, deepGeneAI Agree to Develop Personalized mRNA Cancer Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=2662160207","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662160207?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:08","pubTimestamp":1787746092,"startTime":"0","endTime":"0","summary":"CanSino Biologics'  subsidiary CanSino  Biological Research entered into a strategic cooperation framework agreement with deepGeneAI to jointly develop personalized mRNA therapeutic cancer vaccines.The companies will explore combining CanSino's mRNA vaccine technology with deepGeneAI's tumor neoantigen discovery and design capabilities, according to a Wednesday Hong Kong bourse filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4231","BK4080","BK1191","NETL","ADC","BK1515","BK1574","BK1161","06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143818871","title":"Financial Heavyweights Drive Gains as Multiple Sectors Rally on Policy Support and Solid Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=1143818871","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143818871?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:21","pubTimestamp":1787743279,"startTime":"0","endTime":"0","summary":"On Tuesday (August 26), all three major A-share indices closed higher, with advancing stocks outnumbering decliners across the market. Total turnover on the Shanghai, Shenzhen, and Beijing exchanges...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","159992","IBBQ","512000","159876","KCE","MEDX","BK1574","BK1161","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662184712","title":"RemeGen (SEHK:9995) Stock Profit Surge Meets Doubts Over Earnings Durability","url":"https://stock-news.laohu8.com/highlight/detail?id=2662184712","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662184712?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:43","pubTimestamp":1787741007,"startTime":"0","endTime":"0","summary":"RemeGen stock closed at HK$80.40 on Wednesday, only slightly higher over the past week, even as the latest earnings landed with a jolt. The headline is simple: profitability in Q2 looks striking on paper, with basic earnings per share of ¥7.81 driven by net income of ¥4,334.28m. Yet the stock still trades on a trailing P/E of 6.6x while Hong Kong biotech peers sit far higher. The sentiment gap today relates to investors questioning how much of that earnings power is durable and how much the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/remegen-sehk9995-stock-profit-surge-meets-doubts-over-earnin","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/remegen-sehk9995-stock-profit-surge-meets-doubts-over-earnin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1574","LU2328871848.SGD","BK1161","GXDW","VGFPF","VOTE","DECU","BK1583","PMDE","FEBU","RGLO","LU1969619763.USD","JOYT","09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136653718","title":"Jiangsu Unveils Plan to Encourage Inclusion of Innovative Drugs in Commercial Health Insurance and Mutual Aid Coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=1136653718","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136653718?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:11","pubTimestamp":1787739064,"startTime":"0","endTime":"0","summary":"On August 26, in a financial frontline update, Jiangsu Province issued the \"Three-Year Action Plan for Promoting High-Quality Development of the Biomedical Industry.\" The plan highlights the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","159992","BK4588","XBI","BK4581","IBBQ","LABU","MEDX","BK4585","XLV","159891","BK1574","BK1161","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120378751","title":"Citi Lifts REMEGEN Price Target to HK$127.7, Keeps Buy/High-Risk Call","url":"https://stock-news.laohu8.com/highlight/detail?id=1120378751","media":"Stock News","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120378751?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:16","pubTimestamp":1787735782,"startTime":"0","endTime":"0","summary":"Citi has issued a research report highlighting that REMEGEN (09995) posted a 433% year-on-year revenue surge in the first half, swinging to a profit of RMB 4.66 billion. Management noted that...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525689.USD","LU1244550494.USD","FTXO","LU2417539215.USD","LU2488822045.USD","LU2462157665.USD","LU1074936037.SGD","BK4585","EWH","LU0320765646.SGD","LU1506573853.SGD","LU2148510915.USD","BK4534","09995","BK4588","LU2125154935.USD","LU2456880835.USD","LU1969619763.USD","LU2125154778.USD","LU1064130708.USD","LU0052756011.USD","LU0130102774.USD","LU0648001328.SGD","LU1064131003.USD","LU1162221912.USD","LU1201861249.SGD","LU2360032135.SGD","LU0203345920.USD","LU2328871848.SGD","BK4504","BK4207","LU0072461881.USD","LU0980610538.SGD","LU0106831901.USD","BK1583","LU0098860793.USD","LU0203347892.USD","BK1161","LU0162691827.USD","LU0314106906.USD","LU1267930227.SGD","LU1144417596.USD","LU0130517989.USD","LU1244550221.USD","LU1366192091.USD","LU1668664300.SGD","IE00BSNM7G36.USD","BK0239","LU2236285917.USD","TFNS","LU0170899867.USD","BK1574","IYF","LU0310800965.SGD","688331","BK4566","LU1791807156.HKD","BK4559","LU0477156953.USD","C","LU1244550577.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155760828","title":"CLSA Raises REMEGEN Price Target to HK$144.8, Reiterates Outperform Rating on Strong Q2 Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=1155760828","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155760828?lang=en_us&edition=fundamental","pubTime":"2026-08-26 16:28","pubTimestamp":1787732904,"startTime":"0","endTime":"0","summary":"CLSA has released a research report highlighting that REMEGEN (09995) delivered a remarkable 808.6% year-on-year sales growth in the second quarter of 2026, reaching a net profit of RMB 4.334...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","LU2148510915.USD","688331","BK1161","LU1969619763.USD","LU2488822045.USD","09995","LU1064131003.USD","BK0239","LU1064130708.USD","EWH","LU2328871848.SGD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155077826","title":"Delisting Doesn't Halt Claims! Investors in Poly Pharm (300630) File Another Court Case","url":"https://stock-news.laohu8.com/highlight/detail?id=1155077826","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155077826?lang=en_us&edition=fundamental","pubTime":"2026-08-26 15:21","pubTimestamp":1787728863,"startTime":"0","endTime":"0","summary":"On August 21, 2026, attorney Xu Feng from Shanghai Jiucheng Law Firm, who specializes in stock claim litigation, submitted another round of case filings to the Haikou Intermediate People's Court on...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK0239","01477","300630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":16,"pageCount":1,"totalSize":306,"code":"91000000","status":"200"}]}}